Safety-Related Labeling Changes

Interaction with omeprazole and Breast cancer resistance protein (BCRP) substrate

Trade Name

Lumykras

Updated Section

"4.2 Posology and method of administration , 4.5. Interactions with other medicinal products"

Month

Dec,2023